Market GPS
Investment Outlook 2021
What should be on the radar for investors in 2021? Market GPS helps direction-set with a video summary, in-depth asset class analysis and our latest portfolio manager views.
Subscribe for relevant insights delivered straight to your inbox
Portfolio Manager Andy Acker says the health care sector looks set to ride a number of positive trends into 2021.
How a novel vaccine candidate from Pfizer and BioNTech could shape the trajectory of the global pandemic.
Delivering better-than-expected trial data, a vaccine candidate from Pfizer and BioNTech could mark the beginning of the end of the pandemic and boost confidence in an economic recovery, now underway.
A look at the future of the ACA following the passing of Supreme Court Justice Ruth Bader Ginsburg and what it means for health care stocks.
How COVID-19 is shifting the discourse around health care during the 2020 U.S. election.
New technology and government funding are helping accelerate COVID-19 vaccine development, with potential benefits for the biotech sector over the long term.
COVID-19 cases are mounting in the U.S. But the dynamics of the outbreak are also changing, with important implications for the next phase of the pandemic.
In our ongoing video series on COVID-19, a discussion of the pandemic’s trajectory, vaccine development and investment considerations post-crisis.
An update on vaccines, fatality rates and lessons learned as economies reopen – the latest in a video series on the scientific and investment implications of COVID-19.
A new video series from our health care team offers unique insight into the scientific and investment implications of the COVID-19 crisis.
A new video series from our health care team offers unique insight into the scientific and investment implications of the COVID-19 crisis.
A new video series from our health care team offers unique insight into the scientific and investment implications of the COVID-19 crisis.